4//SEC Filing
REDDICK ANDREW D 4
Accession 0001209191-11-021960
CIK 0000786947other
Filed
Apr 5, 8:00 PM ET
Accepted
Apr 6, 12:05 PM ET
Size
11.8 KB
Accession
0001209191-11-021960
Insider Transaction Report
Form 4
REDDICK ANDREW D
DirectorPresident and CEO
Transactions
- Tax Payment
Common Stock
2011-04-04$3.90/sh−30,263$118,026→ 1,037,346 total - Exercise/Conversion
Stock Options
2011-04-04−112,500→ 337,500 totalExercise: $1.30Exp: 2014-08-12→ Coomon Stock (112,500 underlying) - Exercise/Conversion
Common Stock
2011-04-04$1.30/sh+112,500$146,250→ 1,105,109 total - Tax Payment
Common Stock
2011-04-04$3.90/sh−37,500$146,250→ 1,067,609 total
Footnotes (5)
- [F1]Amount of securities includes 682,500 Restricted Stock Units held by Reporting Person. Absent a change of control, shares of common stock will be distributed in exchange for Restricted Stock Units (after payment of $.01 par value per share) in three equal installments on January 1st of each of 2012, 2013 and 2014.
- [F2]Shares withheld by the Issuer for payment by the Reporting Person to the Issuer of his option exercise price.
- [F3]Shares withheld by the Issuer for payment by the Reporting Person of his tax withholdings.
- [F4]Option exercised is derived from an option to purchase 875,000 shares granted 8/12/2004 (the "Original Option"), which vested as follows: (i) as to 300,000 underlying shares on the date of grant; and (ii) and with respect to the remainder, 25,000 underlying shares vested monthly thereafter commencing on August 31, 2004 until fully vested. On 2/8/2006 the Original Option was bifurcated into two options to comply with Section 409A of the Internal Revenue Code; one with respect to 425,000 shares that had vested on or prior to 12/31/2004 (the "Pre-409A Option") and one with respect to 450,000 shares (the "Post-409A Option"), which vested and was exercisable on the same schedule as in the Original Option. The Pre-409A Option was previously exercised. The Post-409A Option, as amended on 2/8/2006 and 12/2007, is exercisable (absent a change of control) in four equal installments commencing on January 1 of each of 2011, 2012, 2013 and 2014. The 1/1/2011 installment is being exercised herewith.
- [F5]Omitted pursuant to General Instruction 4(c)(iii) to Form 4.
Documents
Issuer
ACURA PHARMACEUTICALS, INC
CIK 0000786947
Entity typeother
Related Parties
1- filerCIK 0001260882
Filing Metadata
- Form type
- 4
- Filed
- Apr 5, 8:00 PM ET
- Accepted
- Apr 6, 12:05 PM ET
- Size
- 11.8 KB